These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7997015)

  • 21. The 4S study: a critical review.
    Pauciullo P
    Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401
    [No Abstract]   [Full Text] [Related]  

  • 22. Cholesterol-lowering, simvastatin, and coronary heart disease.
    Gram J; Jespersen J
    Lancet; 1995 Mar; 345(8949):592. PubMed ID: 7776806
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study.
    Dujovne CA
    Am J Cardiol; 1997 May; 79(10):1387-8. PubMed ID: 9165163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 4S study: a critical review.
    Crepaldi G
    Pharmacol Res; 1997 Mar; 35(3):163. PubMed ID: 9229400
    [No Abstract]   [Full Text] [Related]  

  • 25. Simvastatin and lipoprotein(a).
    Crook D; Sidhu M; Bruce R
    Lancet; 1992 Feb; 339(8788):313-4. PubMed ID: 1346327
    [No Abstract]   [Full Text] [Related]  

  • 26. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
    Lewis-Barned NJ; Ball MJ
    N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scandinavian simvastatin study (4S).
    Wright RA; Flapan AD
    Lancet; 1994 Dec 24-31; 344(8939-8940):1765; author reply 1767-8. PubMed ID: 7997011
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
    Mikhailidis DP; Ganotakis ES; Winder AF
    Atherosclerosis; 1996 Dec; 127(2):287-90. PubMed ID: 9125320
    [No Abstract]   [Full Text] [Related]  

  • 29. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-density-lipoprotein apheresis.
    Olbricht CJ
    Lancet; 1995 Jul; 346(8967):116; author reply 117. PubMed ID: 7603187
    [No Abstract]   [Full Text] [Related]  

  • 31. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prediction of the therapeutic response to cholesterol lowering drugs in an 11-year-old boy with homozygous familial hypercholesterolaemia.
    Bakker HD; Bruin T; Schaap MC; Lansberg PJ; Kastelein JJ
    J Inherit Metab Dis; 1991; 14(3):389-92. PubMed ID: 1663193
    [No Abstract]   [Full Text] [Related]  

  • 33. Cortisol secretion in patients on simvastatin.
    Candrina R; Balestrieri G; Salvi A; Di Stefano O; Spandrio S; Giustina G
    Lancet; 1990 Jan; 335(8680):53. PubMed ID: 1967358
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Scandinavian Simvastatin Survival Study (4S): old wine in new bottles].
    Seidelin KN
    Ugeskr Laeger; 1995 Jun; 157(26):3778. PubMed ID: 7631459
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J; Oette K; Burrichter H
    Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin decreases mortality.
    Shaughnessy AF; Slawson DC
    J Fam Pract; 1995 May; 40(5):498-9. PubMed ID: 7730777
    [No Abstract]   [Full Text] [Related]  

  • 38. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ; Keller U; Oberhänsli A; Riesen WF
    Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 4S study and its pharmacoeconomic implications.
    Reckless JP
    Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.